Skip to main content
. 2021 Jul 23;13(15):3700. doi: 10.3390/cancers13153700

Figure 2.

Figure 2

ExoPAC inhibits proliferation of drug-sensitive and drug-resistant cells. (A) Drug-sensitive (A549) and drug-resistant (A549TR) cells were treated with Exo, ExoPAC and FA-ExoPAC and compared with Abraxane. Antiproliferative activity was determined by MTT assay after 72 h. Exosomal PAC dose-dependently inhibited the proliferation of drug-sensitive A549 (A) and drug-resistant A549TR cells (B).